BioXcel Therapeutics, Inc. (BTAI)
2.07
-0.12
(-5.48%)
USD |
NASDAQ |
Dec 11, 16:00
2.09
+0.02
(+0.97%)
After-Hours: 20:00
BioXcel Therapeutics EPS Diluted (Quarterly): -2.177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xilio Therapeutics, Inc. | -0.113 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.91M |
| Revenue (Quarterly) | 0.098M |
| Total Expenses (Quarterly) | 31.01M |
| Enterprise Value | 117.24M |
| Gross Profit Margin (Quarterly) | 12.24% |
| Profit Margin (Quarterly) | -31.54K% |
| Earnings Yield | -468.5% |
| Normalized Earnings Yield | -426.97 |